Skip to content

Study · Animal study (in vivo) · rat · 2020

1 result

Effect of MGHPPGP Peptide Administered during the Post-Traumatic Period on Morphometric Parameters of the Neocortex and Hippocampus, Hepatocytes, and Epithelium of the Tongue and Small Intestine in Rats.

Fleishman MY, Yakusheva NY, Malofey YB, Tolstenok IV, Innokentiev AA

Bulletin of experimental biology and medicine1 Feb 2020

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats with traumatic brain injury, the glyproline peptide MGHPPGP (Semax sequence) corrected the activity indicators of the nuclear organizer regions in tongue epitheliocytes.

    In plain wordsIn rats with brain injury, the peptide corrected nuclear activity markers in tongue lining cells.

    Peptide
    Semax
    Outcome
    Direction not reportedNuclear organizer region activity in tongue epitheliocytes (AgNOR)
    Study

    ratn: not reported in source

    Wistar male rats, traumatic brain injury (weight drop)
    Outcome group
    Cell proliferation and differentiation · Gastrointestinal
    Studied dose
    1 mg/kg · intraperitoneal · 3 h and days 2, 3, 4, 5 after injuryAs given in this study (rat).

    Source sentences

    Summary
    MGHPPGP peptide corrected the activity indicators of the nuclear organizer regions in epitheliocytes of the tongue.
    2 context sentences
    Summary · context
    The effect of glyproline-containing peptide MGHPPGP (Met-Glu-His-Phe-Pro-Gly-Pro) was studied in experiments on male Wistar rats with modeled traumatic brain injury.
    Summary · context
    The peptide was administered intraperitoneally in a dose of 1 mg/kg in 3 h and on days 2, 3, 4, 5 after injury.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 19:08 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.